Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?

by Ramin Alipour, Arun Azad, Michael S. Hofman
Published 2019-09-01

Editorial: Prostate cancer genomics: Application at different stages of a patient’s journey

by Darren M. C. Poon, Darren M. C. Poon, Arun Azad, Elena Castro, Ravindran Kanesvaran, Oliver Sartor
Published 2022-11-01

Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer

by Mahasha P.J. Perera, Patrick B. Thomas, Gail P. Risbridger, Renea Taylor, Arun Azad, Michael S. Hofman, Elizabeth D. Williams, Ian Vela
Published 2022-01-01

Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late

by Maarten J. IJzerman, Jasper de Boer, Arun Azad, Koen Degeling, Joel Geoghegan, Chelsee Hewitt, Frédéric Hollande, Belinda Lee, Yat Ho To, Richard W. Tothill, Gavin Wright, Jeanne Tie, Sarah-Jane Dawson
Published 2021-01-01

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

by Cristian Udovicich, Jason Callahan, Mathias Bressel, Wee Loon Ong, Marlon Perera, Ben Tran, Arun Azad, Shankar Haran, Daniel Moon, Sarat Chander, Mark Shaw, Renu Eapen, Jeremy Goad, Nathan Lawrentschuk, Declan G. Murphy, Michael Hofman, Shankar Siva
Published 2022-10-01

Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer

by Angelyn Anton, Sruti Pillai, Marie Christine Semira, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond M. Kwan, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Olivia Baenziger, Peter Gibbs, Ben Tran
Published 2022-05-01

481 Phase 1/2 study of THOR-707 (SAR444245), a pegylated recombinant non-alpha IL-2, as monotherapy and in combination with pembrolizumab or cetuximab in patients (pts) with advanc...

by Rui Wang, Judy Wang, Siqing Fu, Arun Azad, Gerald Falchook, Minal Barve, Hui Gan, Tarek Meniawy, Meredith McKean, Tira Tan, Giovanni Abbadessa, David Sommerhalder, Chen Chee, charlotte Lemeque, Nicole Acuff, Helene Pham, Jill Mooney, Neyssa Marina
Published 2021-11-01

Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer

by Elena S. Martens‐Uzunova, Gina D. Kusuma, Stefania Crucitta, Hong Kiat Lim, Crystal Cooper, James E. Riches, Arun Azad, Takahiro Ochiya, Glen M. Boyle, Melissa C. Southey, Marzia Del Re, Rebecca Lim, Grant A. Ramm, Guido W. Jenster, Carolina Soekmadji
Published 2021-08-01

A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol

by David Pryor, Mathias Bressel, Nathan Lawrentschuk, Ben Tran, Jennifer Mooi, Jeremy Lewin, Arun Azad, Duncan Colyer, Nitika Neha, Mark Shaw, Sarat Chander, Paul Neeson, Daniel Moon, Katharine Cuff, Simon Wood, Declan G. Murphy, Shahneen Sandhu, Sherene Loi, Shankar Siva
Published 2021-03-01

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

by Thomas John, Maud H W Starmans, Yao-Tseng Chen, Prudence A Russell, Stephen A Barnett, Shane C White, Paul L Mitchell, Marzena Walkiewicz, Arun Azad, Philippe Lambin, Ming-Sound Tsao, Siddhartha Deb, Nasser Altorki, Gavin Wright, Simon Knight, Paul C Boutros, Jonathan S Cebon
Published 2013-01-01

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

by Jun Guo, Jie Jin, Mototsugu Oya, Hirotsugu Uemura, Shunji Takahashi, Katsunori Tatsugami, Sun Young Rha, Jae-Lyun Lee, Jinsoo Chung, Ho Yeong Lim, Hsi Chin Wu, Yen Hwa Chang, Arun Azad, Ian D. Davis, Marlene J. Carrasco-Alfonso, Bhupinder Nanua, Jackie Han, Qasim Ahmad, Robert Motzer
Published 2018-05-01